Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 912240
                    [Title] => FDA approves new targeted breast cancer drug
                    [Summary] => 
The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.

                    [DatePublished] => 2013-02-23 00:20:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

        )

)

TYKERB AND XELODA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 912240
                    [Title] => FDA approves new targeted breast cancer drug
                    [Summary] => 
The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.

                    [DatePublished] => 2013-02-23 00:20:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

        )

)

abtest

FDA approves new targeted breast cancer drug

February 23, 2013 - 12:20am

The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones.

World